Pay in 4 interest-free payments of $7.17 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
90, 45, '
F., Smith, E
Most studies and clinical guidelines focus on single nightly administration
Precision medicine phase II study evaluating the efficacy of a double immunotherapy by durvalumab and tremelimumab combined with olaparib in patients with solid cancers and carriers of homologous recombination repair genes mutation in response or stable after olaparib treatment
Human mucosa/submucosa interactions during intestinal inflammation: involvement of the enteric nervous system in interleukin-8 secretion
It also participates in several cellular processes related to metabolism and normal cell maintenance
US$ 23.69
US$ 21.35
US$ 20.61
US$ 24.59
US$ 25.34
